Fm1 thanks for your post, regarding a potential variant of Alpha that could be responsible for our current dramatic surge of daily new infections in Austria (well above 10.000 per day)
Unfortunatley, we (the unvaxx.) are locked
up now.... we will see in about 2-3 weeks , if this makes a difference.
Austria Chancellor Moves to Isolate & Lockdown the Unvaccinated as Punishment? Germany & Austria Cases Surge—Leaky Vaccines Involved?
TrialSite reported unvaccinated recently that Austrian Chancellor Alexander Schallenberg was threatening to identify and isolate unvaccinated persons in their homes should the latest surge worsen—leading to ICU utilization above a certain threshold. Now that is a reality as the Central European, German-speaking nation is placing millions of people not fully vaccinated in a lockdown to address the latest surge declared by the Chancellor today. TrialSite emphasized that the nation that is already 65% vaccinated is undeniably dealing with the results of leaky vaccines, that is growing evidence of viral transmission regardless of vaccination or not. Bill Gates, one of the world’s biggest investors and proponents of mass COVID-19 vaccination, declared this recently. Regardless this kind of targeted policy most certainly worries civil libertarian-minded people—especially in this part of the world given historical precedent in the 1930s.
Going on the record, Chancellor Schallenberg told a news conference that he recently shared the news with governors of Austria’s nine provinces. He declared, “We must raise the vaccination rate. It is shamefully low.” At 65%, this is one of the lowest rates in Western Europe, reported Thomson Reuters Foundation today.
Recently Schallenberg positioned the problem as a vaccinated vs. unvaccinated, declaring, “I don’t see why two-thirds should lose their freedoms because one third is dithering.” But given that viral transmission occurs even with the vaccinated, albeit more than likely as a lower rate at least a few months after vaccination, why would such a policy be initiated?
“The data is increasingly apparent that even if all unvaccinated people somehow, somewhat vanished, the vaccinated would still transmit the disease—this is clear from the science as we have tracked several studies indicating this reality declared Daniel O’Connor, founder of TrialSite. And we are not alone at TrialSite. Again Bill Gates declared this fact in a recent interview.
O’Connor continued, “So what do you do, isolate a whole class of person, take away their fundamental rights even though the underlying science for your premise is not correct? That just doesn’t seem right nor the right direction, at least not in a Western Democracy.”
On October 23rd TrialSiteNews reported that Austria was considering a lockdown of the unvaccinated. In this report, Schallenberg was pointing to the vaccine policies of New York or Los Angeles as a way to combat the covid surge.
It appears that because of Austria’s close proximity to Germany, Schallenberg believes these measures are justified. According to a recent New York Times, piece Germany is now going through a new covid wave which the Germans are calling “a pandemic of the unvaccinated.”
Both countries do have a history of lockdowns and plagues. But in Europe, it seems, everything old is new again, and that concerns civil libertarian-minded people.
Central European Surge
SARS-CoV-2 cases in Germany have skyrocketed as a historical number of infections are reported on a daily basis. A record seven-day new daily average of 36,766 cases were reported yesterday in Germany. This is despite the fact that nearly 70% of the nation is vaccinated—almost all adults are immunized against COVID-19.
Deaths are on the rise in Germany as well, with 164 reported as the seven-day new average yesterday.
Austrian cases have skyrocketed as well—shattering records. As of yesterday, the seven-day average for new cases was 10,395, with over 13,000 cases reported on Saturday, November 13. Deaths are also on the rise in Austria
This will probably get lost in the noise of the C-19 chatter, but I think this article that appeared in FORBES online site on November 10th 2021, and that is sponsored by the WEF, should make anyone around here at least rise an eyebrow:
Welcome To 2030 I Own Nothing, Have No Privacy And Life Has Never Been Better.pdf
I attach the pdf printout as the site is not free to read and I got lucky on having been offered 5 articles free of charge for a limited time
Fm1 thanks for your post, regarding a potential variant of Alpha that could be responsible for our current dramatic surge of daily new infections in Austria (well above 10.000 per day)
Unfortunatley, we (the unvaxx.) are locked
up now.... we will see in about 2-3 weeks , if this makes a difference.
The lockdown won't be the difference, it will just seem to look that way. The virus comes in surges along seasonal lines in 4-6 week surges. It's been this way from the start. Soon cases will fall like a rock and then in late December you'll see another small surge over a 4-6 week period. Do they plan on lockdown every 4 months?
In a change from the first three quarters in 2021, uncertainty over COVID-19 is no longer a foremost economic concern to executives, according to the latest McKinsey Global Survey.1 When asked about threats to growth in their countries’ economies, executives now cite mounting fallout on the supply chain—which is also the most common risk to company growth—and inflation more often than the pandemic itself. Having endured as the most-cited risk to domestic growth since March 2020, the pandemic is now cited by just one-quarter of respondents: half the share who did so in September 2021.
Welcome To 2030 I Own Nothing, Have No Privacy And Life Has Never Been Better.pdf
Ida Auken is a Young Global Leader and Member of the Global Future Council on Cities and Urbanization of the World Economic Forum
Yes one would think she is young when she says things like
In our city we don't pay any rent, because someone else is using our free space whenever we do not need it. My living room is used for business meetings when I am not there.
Just think of all the business meetings taking place in all those living rooms across the city. Businesses must be just booming!
I noticed that something slipped through though : she used the words my bike.
Thanks to Jurg above, I ordered some Z-packs (Ziverdo kits) from India last night.
Be aware that Ivermectin is 3 pills of 12mg only. This is OK for India as about 60 kg is a good average weight. For larger people you need a bit a higher dose or take it with food for better resorption may fat is best. But for early treatement it should be enough if you take doxy (10 pills) as direct antibody binding agent for the virus!
Austria Chancellor Moves to Isolate & Lockdown the Unvaccinated as Punishment?
Same as Nazi blaming the "J's". Same passport now for non "J's". Just repeating history. It fascism time again in all western countries.
COVID-19 Cases Reach Parity in Ontario, Canada
November 14, 2021
A light dusting of snow falls over Ontario, Canada, as new COVID-19 cases reported for November 14th reach parity between unvaccinated and fully-vaccinated people: COVID-19 in Ontario. This is the first time the two opposite groups in Canada’s most populated province have recorded an equivalent number of new cases: 300 each. Partially-vaccinated new cases and new cases with unknown vaccination status were also reported: 24 and 42 cases, respectively.
Back on August 9th, unvaccinated new cases in Ontario were more than three times higher than fully-vaccinated new cases. Interestingly, new cases reported for November 14th are pretty close to where they were back in August for unvaccinated people, while fully-vaccinated new cases have risen by approximately 365% since August.
Most of the fully-vaccinated case rise began in late October when above-average temperatures in Ontario dropped to normal. Of relevance, the first week of October, the 40th week of the year, is usually considered the start of the new influenza season in the Northern hemisphere: Influenza | CDC. This is the time of year when vaccines for influenza-like illnesses like COVID-19 are expected to prevent a surge in acute respiratory viral infections as colder weather arrives. But judging by Ontario’s COVID-19 case rise so far, it doesn’t appear to be going well.
UCSD Leads Studies Investigating Medicinal Mushrooms & Chinese Traditional Medicine Targeting COVID-19
Is there any truth to the concept that medicinal mushrooms or traditional Chinese herbal medicine can offer some therapeutic benefit in treatment regimen for COVID-19 infection? Millions of people for example in China are using a traditional herbal medicine called Qing Fei Pai Du Tang for mild COVID-19 for example. This is exactly what University California, San Diego (UCSD)—partnered with University of California, Los Angeles (UCLA) as well as the La Jolla Institute for Immunology seeks to better understand in a few clinical trials. In fact, the collaborative trio of elite Southern California research centers are among the first across America to systematically investigate the use of these integrative medicine approaches applying the gold standard randomized controlled trial. Will these herbal medicines stand up to the test of Western medicine?
A few studies are ongoing or imminent. Presently the academic medical centers are conducting three clinical trials involving between 66 and 80 patients who have tested positive for SARS-CoV-2 and who are quarantined at home with mild-to-moderate symptoms. Two of the Phase 1 studies have been approved by the U.S. Food and Drug Administration (FDA).
In a soon to be commenced study led by Gordon Saxe, MD, PhD, director of research at the Centers for Integrative Health at UC San Diego School of Medicine, the MACH-19 study—a randomized, double-blind, placebo-controlled clinical trial (NCT04951336) evaluates the effect of two polymore mushrooms, Fomitopsis officinalis and Trametes versicolor (FoTv) also known as “Turkey tail” for use as an adjunct to vaccination for COVID-19 in a general population at the time of COVID-19 vaccination.
Ultimately this study evaluates whether medicinal mushrooms could provide a similar lift to COVID-19 booster shots as an adjuvant, a substance which enhances immune response.
What Chinese therapies is UCSD studying?
Another MARCH-19 study evaluates the formulation of 21 Chinese herbs from Taiwan called modified Qing Fei Pai Du Tang (mQFPD), widely used as a COVID-19 remedy in China.
Also called MACH-19, this study (NCT04939415) evaluates mQFPD as a COVID-19 outpatient treatment with mild-to-moderate symptoms assigned to self-quarantined and home management. What is the safety and feasibility of the use of mQFPD vs. placebo in 66 participants? If this study goes well, they study team plans a larger study population.
What are the ancient biological therapies in use?
In the medicinal mushroom studies both mushrooms have immunomodulatory properties which can possibly boost antibody titers in response to vaccination as compared to vaccination alone. The study investigators suggest that these ancient biological therapies also possess immunomodulatory properties that may actually also decrease vaccine-related side effects after COVID-19 vaccination.
Thus, the study team designed in the protocol the goal of evaluating the safety and feasibility of the use of FoTv vs. placebo as well as an evaluation of the effect on post vaccination clinical symptoms, as well as neutralizing antibody and immune response in what should be 45 study participants.
Meanwhile mQFPD was selected as the Chinese herbal medicine is widely in use in China as a treatment for COVID-19. However, there is a lack of systematic medical evidence that this product actually works.
What evidence is there for these claims?
For example, in a preclinical study published in the March 2019 issue of Mycology, the study team found that agarikon was found to inhibit viruses including influenza A (H1N1), influenza A (H5N1) and herpes.
Moreover, as published recently in UCSD News, Dr. Saxe believes medicinal mushrooms could inhibit viral replication. He seeks to test this hypothesis against SARS-CoV-2 in a Phase 2 trial.
As far as mQFPD, millions of Chinese use it as a treatment for COVID-19—but no studies have produced solid medical evidence.
What studies in China show positive results?
One meta-analysis led by investigators from Lanzhou University in China identified 16 studies with 11,237 patients and found that QFPD combined with conventional treatment might be effective for COVID-19 patients. The results were published in Frontiers in Pharmacology. However, the authors, led by Long Ge (Lanzhou University) require larger studies.
What’s the UCSD PI POV?
According to Dr. Saxe “Mushrooms have the advantage that they co-evolved with us.“ He continued So bacteria, viruses and other fungi prey on mushrooms just like they prey on humans. And mushrooms have developed exquisite defenses against those pests, and we believe they can confer those to us when we eat them.”
When is data expected from the UCSD -led study?
According to UCSD some initial safety data from these trials is expected at the end of this year with efficacy data ready within a year.
The FDA’s POV broadening?
Dr. Saxe went on the record that the FDA is opening up and becoming more friendly to integrative, complementary medicine. Saxe is happy to secure FDA approval, noting that this is a sign that “Western scientific minds are broadening.”
About the UCSD Center for Integrative Medicine
UCSD Center for Integrative Medicine operates virtually across UCSD’s departments and divisions, focusing on whole-person wellness by addressing the individually physician as well as lifestyle, emotional psychological and spiritual needs. This center blends science of medicine with the art of healing to foster an innovative, dynamic and holistic environment across UCSD.
Lead Research/Investigator
Gordon Saxe, MD, PhD, director of research at the Centers for Integrative Health at UC San Diego School of Medicine
Indian Experts Also Omit Key Risk Factors Associated with Mass Child COVID-19 Vaccination
Why is there such a big push to vaccine every child around the world? Is it because the underlying premise in the war against COVID-19 is that the eradication of SARS-CoV-2 will only happen via mass vaccination—that the children along with the “unvaccinated” represent the last “reservoirs” of the pathogen—SARS-CoV-2? Addressing that question was Bill Gates himself, one of the biggest mass vaccine proponents, recently challenging the premise that the current crop of vaccines on the market can stop transmission. If this is the case, then the only reason to vaccinate young children would be to protect them against serious infection leading to hospitalization. But then the risk-benefit profile must strongly lean in favor of vaccination—that is the risks of side effects and adverse events must be materially trumped by the risks of SARS-CoV-2 severe infection in children aged 5 to 11 years of age. Recently in India’s Sunday Guardian Live, a couple Indian physician-researchers shared their optimistic opinions as to the safety of the COVID-19 vaccines as used in children. Experts ranged from Dr. Rajeev Kaul, Professor and microbiologist from University of Delhi to Dr. Debayan Mallik, head of the Rural Health Training Center, Jagannath Gupta Institute of Medical Sciences as well as Hospital Calcutta shared their upbeat opinions on the COVID-19 vaccines for the young. But are their answers any better than experts we tracked recently in America?
Study Data Seems Positive. But…
The experts in India appear to base most of their opinion on the clinical trials coming out of India. Even though these studies haven’t yet tracked long term outcomes, nonetheless that is what they have to go with. For example, Dr. Kaul shared “Bharat Biotech has recently submitted data to Central Drugs Standard Control Organization (CDSCO) regarding Covaxin trial in children of 2 years age and above. This data shows positive recommendations indicating that Covaxin is safe in children. Both Pfizer and Moderna have also declared that their vaccine is safe in children aged 6 to 11. These trials have shown that fatigue, headache, fever and pain at the site of injection were common side effects of the vaccine in children, as has been the case in adults. Therefore, it can be concluded that the safety profile of these vaccines in children is favourable.”
Moreover, Dr. Mallik shared the same optimistic view for the same underlying reasons—that the pharmaceutical company’s clinical trials shared positive results with an acceptable safety risk declaring “The vaccines are safe to be used on children.”
Mallik also slipped “Whether there will be any serious aftereffects in vaccinated children, however rare they may be, it can only be determined after data from large scale trials will be analysed,”
Critique of this POV
Note that the Indian microbiologist and key opinion leader qualifies his state by declaring that the pharmaceutical companies of Pfizer and Moderna made a declaration that the vaccine is safe in children aged 5 to 11. But as TrialSite has chronicled recently the FDA failed to review the Pfizer data prior to the the last Oct 26 VRBPAC meeting. This means that the regulators just assumed that everything that the pharmaceutical company declared was accurate, was in fact, accurate.
And despite the fact that the FDA delayed emergency use for Moderna for the aged 5 to 11 cohort—due to concerns of myocarditis—the Indian physician declared that the vaccine should be good because Moderna said so.
TrialSite reminds all that all of the Scandinavian nations have either temporarily or permanently halted the use of the Moderna vaccine called mRNA-1273 on young people due to safety concerns.
Children are society’s most vulnerable, and any mass vaccination program must ensure all risks are commonly understood.
TrialSite raised concerns for children aged 5 to 11 based on the October 26 FDA VBRPAC and subsequent CDC ACIP meetings including:
Vaccines were produced with unprecedented speed. This isn’t a bad thing in and of itself—in fact, it is good for the progress of medicines development, but we shouldn’t be in a rush to inoculate an entire young generation until there is more safety data and an improved risk profile. For example, the amount of safety that accumulated for other vaccines required for school should be comparable to the current ones. It’s also worth noting that most of the vaccines approved for child vaccine-preventable illnesses are for diseases that target children with more severe symptoms. COVID remains significantly deadlier in the elderly.
The risk-benefit analysis isn’t what the CDC claims. Children have a very low serious illness and death rate. Nearly all of the children that have been severely ill or have died, which is a very small amount to begin with, have had underlying comorbidities. See slide #19. The FDA analysis led to the conclusion that the vaccine represented a 6.6x benefit. However, after a review by expert David Wiseman, the risk-benefit ratio becomes negative 1.8, meaning the risk is higher than the benefit. This is because of several factors, including waning effectiveness to non-myocarditis serious adverse events.
We should be focused on specific risk cohorts among the young, and not focus on a one-size-fits-all vaccination approach. This includes no mandates for such young children, until we have at least years of hard data.
The FDA acknowledged that they didn’t thoroughly review the data at the VRBPAC meeting on October 26. See slides #18-19. Critical questions remain.
On hesitancy about safety, Dr. Eric Rubin declared that we are “never going to learn how safe this vaccine is unless we start giving it.” Note PolitiFact provides content for review but the point is that there is no long-term data in a very vulnerable and low-risk group. Shouldn’t we be as careful as possible with our children and ensure more data is available?
Whistleblowers reveal stark data quality problems with the Pfizer-BioNTech study as reported in the BMJ. Even when Pfizer was made aware of quality issues with one managing research company, they handed them four more vaccine contracts, including one for vaccines in children.
Disclosures that some of the manufacturing inputs changed should be associated with revalidation of production systems and outputs. Specifically, Pfizer changed the children’s formula to produce the product. This is a deviation from the study protocol. Under any normal conditions this change would need to be validated.
Call to Action: Why would all of these doctors go on record making claims of safety when sophisticated nations such as Norway, Sweden, Denmark, Iceland and Finland are stopping the use of at least one of the mRNA-based vaccines by young people? Why aren’t these doctors raising a more holistic perspective
The experts in India appear to base most of their opinion on the clinical trials coming out of India. Even though these studies haven’t yet tracked long term outcomes, nonetheless that is what they have to go with. For example, Dr. Kaul shared “Bharat Biotech has recently submitted data to Central Drugs Standard Control Organization (CDSCO) regarding Covaxin trial in children of 2 years age and above. This data shows positive recommendations indicating that Covaxin is safe in children.
These are the today's Dr. Mengele. Until two years ago a child vaccine did need a 10 years follow study until broadly accepted and being ready for mass application.
Pfizer undoubtfully induces cancer on the long haul. In children this has a multiplicative effects as mitosis is very active every day. We know from early smokers that starting (1 package/day) before age 16 (men) 14 (woman) reduces your live spawn by at least 10 years even if you fully stop later. If you start past 25 then a full stop can almost reverse the damage.
So for me everybody that RNA "vaccinates" a child (except in some rare comorbidity cases) is a drug addicted junky that potentially kills his child.
this is another example why kids don't need the jab as they have more contact with corona colds and mount a better t cell response.
Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2
Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2 - Nature
Abstract
Individuals with potential exposure to SARS-CoV-2 do not necessarily develop PCR or antibody positivity, suggesting some may clear sub-clinical infection before seroconversion. T-cells can contribute to the rapid clearance of SARS-CoV-2 and other coronavirus infections1–3. We hypothesised that pre-existing memory T-cell responses, with cross-protective potential against SARS-CoV-24–11, would expand in vivo to support rapid viral control, aborting infection. We measured SARS-CoV-2-reactive T-cells, including those against the early transcribed replication transcription complex (RTC)12,13, in intensively monitored healthcare workers (HCW) remaining repeatedly negative by PCR, antibody binding, and neutralisation (seronegative HCW, SN-HCW). SN-HCW had stronger, more multispecific memory T-cells than an unexposed pre-pandemic cohort, and more frequently directed against the RTC than the structural protein-dominated responses seen post-detectable infection (matched concurrent cohort). SN-HCW with the strongest RTC-specific T-cells had an increase in IFI27, a robust early innate signature of SARS-CoV-214, suggesting abortive infection. RNA-polymerase within RTC was the largest region of high sequence conservation across human seasonal coronaviruses (HCoV) and SARS-CoV-2 clades. RNA-polymerase was preferentially targeted (amongst regions tested) by T-cells from pre-pandemic cohorts and SN-HCW. RTC epitope-specific T-cells cross-recognising HCoV variants were identified in SN-HCW. Enriched pre-existing RNA-polymerase-specific T-cells expanded in vivo to preferentially accumulate in the memory response after putative abortive compared to overt SARS-CoV-2 infection. Our data highlight RTC-specific T-cells as targets for vaccines against endemic and emerging Coronaviridae.
Noted Ivermectin Advocate Dr. Paul Marik Files Suit Against his Employer, Sentara Healthcare, over Differences in COVID Treatment Approach
by Stephen Ditmore
“Patients come to the ICU because they failed treatment on the floor. The treatment they get on the floor is remdesivir and dexamethasone, and once they’ve failed, they have clearly failed, and you have to escalate therapy. And that’s what we do when the patient is admitted to the ICU, we escalate care, and we escalate care by giving them high dose methylprednisolone, ascorbic acid, and then we add these other medications*.”
“What happened was, I was not allowed to use these medications*, so I was not allowed to escalate care, so I watched idly by as my patients, these were my patients, I was the attending of record, I watched helplessly as these patients progressed, got progressively worse, and they died. It was an awful, harrowing experience that I do not want to go through ever again in my life. I was the bedside physician, I was in charge of looking after the patient, and I was denied my absolute duty to do the best for the patient that I could – to prescribe safe, FDA approved medications that have shown to be safe and effective for the treatment of COVID.”
“This is not about financial reward, this is not about my job, this is about allowing physicians like myself, across the country, to do what physicians do, to prescribe medications at the bedside that they believe are most effective for their patients. We should recognize that in hospitals, up to about 30% of medications are used off-label every single day, and it’s just part of regular medical care.”
– Paul E. Marik, MD, FCCP, FCCM
Director, Intensive Care Unit
Sentara Norfolk General Hospital
November 10, 2021
*At issue is a memorandum issued by Dr. Joel Bundy, Sentara Healthcare’s Chief Quality and Safety Officer, dated Sept. 27, 2021 and announced to hospital physicians by email on October 6. Dr. Marik’s complaint takes issue with the new hospital guidelines’ prohibition of ascorbic acid (vitamin C), ivermectin, fluvoxamine, and several anti-androgens for use treating COVID-19 patients. The memorandum allows for steroid escalation to 80mg BID methylprednisolone (without endorsing it).
Dr. Marik rotates into the Norfolk General Hospital ICU as the on-call attending physician on a monthly one-week-in-four schedule, and his treatment of COVID patients differs from that used by the other, less experienced attending physicians at the Norfolk ICU, who do not employ the MATH+ Protocol. Comparing the mortality rate of the COVID patients under his direct care to that of COVID patients treated by other physicians at the ICU, Dr. Marik estimates that his treatment has reduced ICU COVID patients’ mortality “without question, by half.”
There are hospitals at which the entire critical care units have adopted MATH+, prominently two in Houston hospitals under the leadership of Dr. Joseph Veron, Chief of Staff and Chief of Critical Care Services. In Dr. Marik’s complaint, Dr. Veron attests:
“Over the past 18 months of our hospitals’ use during the COVID pandemic, I can confidently testify that the MATH+ protocol saves lives, and saves them in substantial numbers. I know this first, and foremost, from my own experience in our hospital, where we were able to lower our mortality for COVID-19 patients (both critically ill and those on regular wards) beginning in March 2020 (when we began utilizing the MATH+ protocol) to 4.4% as of August 2020-a dramatic improvement over the national average of 22% over the same time period. Reported mortality averages across the globe have varied widely, but our hospitals’ results have successfully maintained far lower patient mortality rate-between 4.4% and 7%, to the present day. Multiple studies report much higher national mortality averages, including one such study that I participated in and published in June 2021 in the Journal of Community Medicine and Public Health Reports. That study, reviewing some 85 hospital studies worldwide, establishes an average 28-day hospital mortality rate among COVID-19 patients of 20% nationwide, and 21% globally.”
“To this day, even with the advent of the “Delta variant” of COVID-19, our mortality rate has not risen above 7%. Bottom line: our hospitals’ use of the MATH+ protocol has reduced mortality of hospitalized COVID-19 patients by at least 50% below the national average.”
“Our experience of substantially lowering the mortality rate using MATH+ protocols is made all the more remarkable by the fact that our hospital now routinely admits severely ill patients referred by other hospitals and ICUs that for whatever reason are not administering the MATH+ protocol. These patients, in many cases, are those that the referring hospital/physician has determined will not likely survive. As our success has become increasingly known among treating physicians in the Houston area and beyond, those referrals have risen to account for approximately 10- 15% of our admitted COVID-19 patients. While we have been able to cure the vast majority of those patients using MATH+, in my opinion, the advanced stage of the disease we see in the referred patients likely accounts for some of the increase in our mortality rate for COVID patients. Nevertheless, we are currently experiencing a mortality rate in our hospitals of just 5%.”
In 2020 Dr. Marik, together with other critical care specialists including Dr. Veron and Dr. Pierre Kory, co-founded a nonprofit charitable organization, the Front Line COVID-19 Critical Care Alliance (“FLCCC”). Their purpose was to “gather, research and share information among health care professionals and the public,” and they set about analyzing, devising, and publicizing best-practice treatment regimens for the novel SARS-CoV-2 coronavirus. Dr. Marik and his colleagues were among the first to use high dose steroids against COVID-19; today, the FLCCC’s multi drug regimen for COVID, known as the MATH+ Protocol, consists of (in alphabetical order): Ascorbic Acid (Vitamin C); Atorvastatin; Bicalutamide; Cyproheptadine; Dutasteride; Famotidine; Finasteride; Fluvoxamine; Heparin, lvermectin; Melatonin; Methylprednisolone; Nitazoxanide; Statin; Therapeutic Plasma Exchange; Thiamine; Vitamin D; and Zinc.
At issue is the right of attending physicians and their patients to utilize the full palette of pharmacology at their disposal. One has to wonder what motivates hospital administrators to interfere with that, what pressures they face, and from whom? To some it appears “evidence based medicine” is so focused on certain types of RCT’s that those who write guidelines and administrators who follow them lose perspective on the clinical experience of their senior physicians, and in some cases on patient outcomes. Says Marik:
“This case is about doctors, having the ability to honor their Hippocratic Oath, to follow evidence-based medicine, and to treat our patients the best we know how. Corporations and faceless bureaucrats should not be allowed to interfere with doctor-patient decisions, especially when it can result in harm or death. I refuse to watch another patient die from COVID-19 knowing that I was not allowed to give them proven treatments that could have saved their life.”
On a personal note:
Full disclosure, I have been corresponding with Dr. Marik for nearing a year and a half, and am grateful to him for the many times he has answered this health journalist’s pesky questions. We are co-authors on two papers, one of them with a lead author who is notably not in lockstep with all of Dr. Marik’s ideas, yet who Paul worked well with where they found common ground. I originally came across Dr. Marik’s protocols on the Eastern Virginia Medical School website; whatever protocols are now there require staff / student login. Older information is on other sites, but visit flccc.net or covid19criticalcare.com for the latest version of the MATH+ Protocol.
I am not an MD, but have some quality assurance training. Noting that the issuer of the memo, Dr. Joel Bundy, is a six-sigma black-belt along with being an MD, I have some things to say, one quality assurance pro to another.
A signal goal of the modern quality assurance movement, distinct from old-style quality control, is fostering a culture of continual improvement within organizations and involving everyone in that project. In the spirit of William Edwards Deming I’ve got to tell y’all, handing down edicts from on high is not how that happens. So I ask, respectfully, what problem was that memo intended to solve? Do you think, just maybe, there’s a better way?
While scientists & physicians may talk about RCTs being key to the practice of “evidence based medicine”, in QA outcomes are evidence. If the claims of lower death rates made by both Dr. Paul Marik and Dr. Joseph Verone are accurate, there’s something to be said for stepping away from individual trees (drugs) and looking at the forest. As to whether Sentara has met or exceeded customer expectations, please don’t count the dead as yes votes because they’re not complaining; that would be a stretch. But perhaps I am being naïve in assuming the patient is the customer – so I’m asking: who do you consider to be your customer, Dr. Bundy?
To your credit, Dr. Bundy, your memo left open the possibility of novel drugs being utilized in the context of a clinical trial. I was not invited to the brainstorming session, but I’d like to throw an idea against the wall anyway, to see if it sticks. One could imagine Norfolk General Hospital’s ICU embracing its director’s protocols as they apply to that department, then running clinical trials not where drugs are added one at a time, but where drugs are selectively removed, to see what effect substituting a placebo has in each case. We do, after all, have an incoming FDA Commissioner, Dr. Robert Califf, known to support certain novel clinical trial designs in the service of “the question we actually want to answer.”
Please take what you will from my remarks, Dr. Bundy; I sincerely hope you can resolve these issues within your organization to the benefit of all involved. My instinct would be to call QA friends for a chat before calling lawyers, but that’s just me.
Reported mortality averages across the globe have varied widely, but our hospitals’ results have successfully maintained far lower patient mortality rate-between 4.4% and 7%, to the present day. Multiple studies report much higher national mortality averages, including one such study that I participated in and published in June 2021 in the Journal of Community Medicine and Public Health Reports. That study, reviewing some 85 hospital studies worldwide, establishes an average 28-day hospital mortality rate among COVID-19 patients of 20% nationwide, and 21% globally.”
Yet the western medical establishment is actively trying to prevent successful doctors from being successful in treating their patients, and saving many lives in the process. Something is very wrong with this picture.
If given the option, would anyone chose to be admitted to the hospital with the 20% COVID mortality, instead of the one with 4.4%?
Does Covid-19 follow a similar seasonal pattern to flu?
Anticipating the seasonality of coronavirus is a key factor in fighting its spread, say scientists
It is well known that influenza is seasonal, peaking in the winter in temperate regions and during the wet season in tropical locations. So does Covid-19 follow a similar seasonal pattern?
To answer this question scientists compared coronavirus rates between March 2020 and March 2021 from five countries – Canada, Germany, India, Ethiopia and Chile – with daily mean temperature, humidity, ultraviolet radiation and air-drying capacity (a measure of how quickly droplets evaporate).
In countries with temperate climates they found Covid-19 peaked during the winter months, when temperature and humidity were low. Meanwhile, in countries with tropical climates the cases peaked during the summer monsoons, when humidity was high.
The results, published in the journal GeoHealth, reveal that there were two variables – ultraviolet levels and air-drying capacity – that consistently correlated with Covid-19 levels in all countries. Bright sunshine and fast evaporation were associated with falling rates of coronavirus, while cloudy skies and slow evaporation appear to aid the spread of the virus.
Anticipating the seasonality of Covid-19 will be important in combating its spread, ensuring booster vaccines are given before the peak season takes-off, for example. But seasonality is only one factor, we shouldn’t drop our guard just because it is sunny and dry.
Vaccines were trialed during the summer months when the virus is weak. No wonder they thought breakthroughs would be rare. But they are the idiots errrr experts!
"Vaccines were trialed during the summer months when the virus is weak. No wonder they thought breakthroughs would be rare. But they are the idiots errrr experts!"
Easy to judge and claim today having millions of good data around the globe on the table. Should they have known and adopt their trials when they started with their trials early 2020? Not sure, but they probably had other problems back then...
The lockdown won't be the difference, it will just seem to look that way. The virus comes Soon cases will fall like a rock and then in late December you'll see another small surge over a 4-6 week period. Do they plan on lockdown every 4 months?
I guess so. If the numbers go back to "normal", it's an arguement for the decision makers.
Next time they will do the same again.... send the unvaxx. persons to law enforced, temporal isolation. I don't think this will be examined in too much detail. This is of no benifit for politicians, since uncomfortable questions might come up.
We in AT live more and more in a banana republic!
That is why I like the open exchange here! Thumbs up for LF!
Despite all this crap (excuse my language) , I think we should more focus on CF, to mitigate the next crisis.
Austria Chancellor Moves to Isolate & Lockdown the Unvaccinated as Punishment?
It certainly is.....
this is another example why kids don't need the jab as they have more contact with corona colds and mount a better t cell response.
Great paper! Relink from FM1: https://www.nature.com/articles/s41586-021-04186-8
We did already know that between 15..30% of ICU and front line healthcare personal was immune without ever being PCR+. The paper explains why this happens. These poor guys will not even show elevated IG-G and will not get a vaccine passport... Despite being the best covered on the planet!
